Summary
This study evaluated the effects of zinc supplementation on inflammation in kidney dialysis (hemodialysis) patients. Hemodialysis is the most common method used to treat kidney failure and is associated with increased inflammation. In the study, 55 hemodialysis patients were given zinc or placebo for 42 days. The results showed that zinc supplementation decreased inflammation in hemodialysis patients. Further details can be found in the study.
References
Ali A Rashidi, Mosa Salehi, A Piroozmand, Mohammad M Sagheb